Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults

计划入组 200 人 · 首次发布于 2025 年 10 月 10 日

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

计划入组 1,051 人 · 首次发布于 2023 年 8 月 18 日

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

计划入组 4,338 人 · 首次发布于 2022 年 9 月 16 日

SARS-CoV-2 vaccine

KP-309 series

KP-606

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

FDA Approves Updated COVID-19 Vaccines Targeting Omicron KP.2 Strain for 2024-25 Season

KP.2 COVID-19 Vaccines Demonstrate Sustained 70% Effectiveness Over 12 Months in Major US Study

Pfizer and BioNTech's Omicron KP.2-Adapted COVID-19 Vaccine Receives Positive CHMP Opinion